                         SEQUENCE LISTING

<110>  The United States of America, as represented by the 
       Secretary, Department of Health and Human Services
 
<120>  MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF 
       THEIR USE

<130>  4239-105376-02

<150>  US 63/109,707
<151>  2020-11-04

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic guide RNA

<400>  1
uuuugcaguu uaucaggaug                                                   20


<210>  2
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic guide RNA

<400>  2
aaaacagguc agagauggcc                                                   20


<210>  3
<211>  20
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic guide RNA

<400>  3
uguauuucca aagucccacu                                                   20


